Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases

Current Allergy and Asthma Reports
Bridget P Kaufman, Andrew F Alexis

Abstract

Biologics and small molecules are key therapeutic options in the treatment of chronic immunologic and allergic skin conditions. By directly targeting innate and inflammatory responses within the skin, including pro-inflammatory cytokines and cellular signaling pathways, these new agents have the potential to counteract the inflammatory cascade responsible for various conditions, including psoriasis and atopic dermatitis. Over the past decade, groundbreaking research identifying key cytokines and receptors involved in the pathogenesis of these diseases has allowed for the development of highly efficacious biologics and small molecules that are associated with unprecedented rates of skin clearance and favorable adverse event profiles. This narrative review evaluates new and upcoming biologic and small molecule agents for the treatment of two allergic/immunologic skin diseases-atopic dermatitis and psoriasis. Numerous small molecules and biologics targeting TNF-α, IL-12/23, IL-17 and IL-17R, and IL-23 are commercially available for the treatment of psoriasis, and newer agents are in various stages of development. Currently, dupilumab, a monoclonal antibody that blocks IL-4R∝, is the only approved biologic for atopic dermatitis. An...Continue Reading

References

Sep 1, 1988·The Journal of Experimental Medicine·D A Lebman, R L Coffman
Sep 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ichiro NomuraDonald Y M Leung
May 19, 2004·Allergy·D SimonH-U Simon
Feb 8, 2006·The Journal of Allergy and Clinical Immunology·Eniko SonkolyBernhard Homey
Jul 4, 2006·The Journal of Allergy and Clinical Immunology·Michael J CorkRachid Tazi-Ahnini
Jul 6, 2007·The Journal of Investigative Dermatology·Mitsutoshi TominagaKenji Takamori
Jan 2, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Byung Eui KimMichael D Howell
Apr 4, 2008·The Journal of Investigative Dermatology·Michael D HowellDonald Y M Leung
Sep 2, 2009·The Journal of Allergy and Clinical Immunology·Michael D HowellDonald Y M Leung
Jan 30, 2010·The Journal of Allergy and Clinical Immunology·Kathleen C Barnes
Oct 29, 2011·Drug Discovery Today·Pnina FishmanKenneth A Jacobson
Nov 2, 2011·Acta Dermato-venereologica·Stephan NobbeGünther F L Hofbauer
Jul 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·M Sokołowska-WojdyłoB Nedoszytko
Jan 8, 2013·Trends in Immunology·Michelle A LowesJames G Krueger
Jul 3, 2013·International Archives of Allergy and Immunology·Shuba Rajashri IyengarKari Christine Nadeau
Jul 10, 2014·The New England Journal of Medicine·Lisa A BeckAllen R Radin
Jul 10, 2014·The New England Journal of Medicine·Richard G LangleyUNKNOWN FIXTURE Study Group
Oct 15, 2014·Journal of the American Academy of Dermatology·Kim PappPaul Klekotka
Jul 8, 2015·The British Journal of Dermatology·K A PappUNKNOWN OPT Pivotal 1 and OPT Pivotal 2 investigators
Oct 1, 2015·The New England Journal of Medicine·Mark LebwohlAjay Nirula
Oct 3, 2015·The Journal of Allergy and Clinical Immunology·Shinji NodaEmma Guttman-Yassky
May 22, 2016·Journal of Cutaneous Medicine and Surgery·Mohn'd AbuHilalNeil Shear
Oct 21, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·F ValenzuelaC Mamolo
Jun 15, 2016·The New England Journal of Medicine·Kenneth B GordonUNKNOWN UNCOVER-3 Study Group
Jun 16, 2016·Experimental Dermatology·Saakshi KhattriEmma Guttman-Yassky
Aug 2, 2016·Journal of the American Academy of Dermatology·April W ArmstrongJames E Signorovitch
Aug 9, 2016·The Journal of Allergy and Clinical Immunology·Thomas WerfelCezmi A Akdis
Aug 21, 2016·The Journal of Allergy and Clinical Immunology·Hsiao-Han WangYu-Chen Huang
Oct 7, 2016·Journal of the American Academy of Dermatology·Alice GottliebMarina Milutinovic

❮ Previous
Next ❯

Citations

Sep 8, 2019·Archives of Dermatological Research·Julie K NguyenJared Jagdeo
Apr 12, 2019·Dermatologic Therapy·Kemal ÖzyurtMustafa Atasoy
May 28, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Thomas Litman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

Cutis
Yasaman Mansouri, Gary Goldenberg
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
Thomas WerfelA Heratizadeh
Immunology and Allergy Clinics of North America
James M FernandezDavid M Lang
© 2022 Meta ULC. All rights reserved